Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Cited by (1,007)

Items 201–300 of 1,007

1. Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
   Dominick Joseph Angiolillo, Michael S. Firstenberg, Matthew J. Price, Pradyumna E. Tummala, Martin Hutyra, Ian J. Welsby, Michele Doughty Voeltz, Harish Chandna, Chand Ramaiah, Miroslav Brtko et al. · 2012 · JAMA
2. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
   Hani M. Jneid, Jeffrey L. Anderson, R. Scott Wright, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Théodore G. Ganiats, Abraham Michael Lincoff et al. · 2012 · Journal of the American College of Cardiology
3. Primary and Secondary Prevention of Cardiovascular Disease
   Vandvik, Per Olav, Lincoff, A. Michael, Gore, Joel M., Gutterman, David D., Sonnenberg, Frank A., Alonso-Coello, Pablo, Akl, Elie A., Lansberg, Maarten G., Guyatt, Gordon H., Spencer, Frederick A. · 2012 · Chest
4. CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events: A Systematic Review and Meta-analysis
   Holmes, Michael V., Perel, Pablo, Shah, Tina, Hingorani, Aroon D., Casas, Juan P. · 2011 · JAMA
5. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
   Christa Boer, Michael Isaäc Meesters, Milan Milojevic, Umberto Benedetto, Daniel Bolliger, Christian von Heymann, Anders Jeppsson, Andreas Koster, Ruben L.J. Osnabrugge, Marco Ranucci et al. · 2017 · Journal of Cardiothoracic and Vascular Anesthesia
6. Paraoxonase-1 is a major determinant of clopidogrel efficacy
   Heleen J. Bouman, Edgar Schömig, Jochem Wouter van Werkum, Janna Velder, Christian M. Hackeng, Christoph Hirschhäuser, Christopher M. Waldmann, Hans‐Günther Schmalz, Jurriën M. ten Berg, Dirk Taubert · 2010 · Nature Medicine
7. Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction
   Tomas Jernberg · 2011 · JAMA
8. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting
   Stephanie H. Wilson, Panayotis Fasseas, James L. Orford, Ryan J. Lennon, Terese T. Horlocker, Nina E. Charnoff, Steven Melby, Peter B. Berger · 2003 · Journal of the American College of Cardiology
9. Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
   APPRAISE Steering Committee and Investigators · 2009 · Circulation
10. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
    James, Stefan, Angiolillo, Dominick J., Cornel, Jan H., Erlinge, David, Husted, Steen, Kontny, Frederic, Maya, Juan, Nicolau, Josë C., Spinar, Jindrich, Storey, Robert F. et al. · 2010 · European Heart Journal
11. ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
    Neena S. Abraham, Mark Andrew Hlatky, Elliott Marshall Antman, Deepak L. Bhatt, David J. Bjorkman, Craig B. Clark, Curt Daniel Furberg, David A. Johnson, Charles J. Kahi, Loren Laine et al. · 2010 · Circulation
12. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
    Stephen D. Wiviott, Eugene Braunwald M. D, Carolyn H. McCabe, Iván Horváth, Mátyás Keltai, Jean-Paul R. Herrman, Frans Van de Werf, William E. Downey, Benjamin M. Scirica, Sabina A. Murphy et al. · 2008 · The Lancet
13. Secondary Prevention After Coronary Artery Bypass Graft Surgery
    Alexander Kulik, Marc Ruel, Hani M. Jneid, Thomas Bruce Ferguson, Loren F. Hiratzka, John S. Ikonomidis, Francisco Alejandro López-Jiménez, Sheila M McNallan, Mahesh J. Patel, Veronique Lee Roger et al. · 2015 · Circulation
14. Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
    Paul Alfred Gurbel, Kevin P. Bliden, Kathleen A. Butler, Mark J. Antonino, Cheryl Wei, Renli Teng, Lars Rasmussen, Robert F. Storey, Tonny Nielsen, John W. Eikelboom et al. · 2010 · Circulation
15. Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease
    Dominick Joseph Angiolillo, Steven B. Shoemaker, Bhaloo Desai, Hang Yuan, Ronald K. Charlton, Esther Bernardo, Martin M. Zenni, Luis A. Guzmán, Theodore A. Bass, Marco Antonio Costa · 2007 · Circulation
16. Generalisability in economic evaluation studies in healthcare: a review and case studies
    Mark John Sculpher, Francis Pang, Andrea Manca, Michael Drummond, Su Golder, Hege Urdahl, Linda Mary Davies, Alison J. Eastwood · 2004 · Health Technology Assessment
17. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
    Beckman, Joshua A., Paneni, Francesco, Cosentino, Francesco, Creager, Mark A. · 2013 · European Heart Journal
18. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis
    Jennings, Lisa · 2009 · Thrombosis and Haemostasis
19. The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
    Victor J. Dzau, Elliott Marshall Antman, Henry R. Black, David L. Hayes, JoAnn Elisabeth Manson, Jorge Plutzky, Jeffrey J. Popma, William G. Stevenson · 2006 · Circulation
20. Timing of TIAs preceding stroke
    Peter Malcolm Rothwell, Charles P Warlow · 2005 · Neurology
21. Management of Cocaine-Associated Chest Pain and Myocardial Infarction
    James McCord, Hani M. Jneid, Judd E. Hollander, James A. de Lemos, Bojan Cercek, Priscilla Y. Hsue, W. Brian Gibler, E. Magnus Ohman, Barbara J. Drew, George J. Philippides et al. · 2008 · Circulation
22. Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
    Jorn Brouwer, Vincent Johan Nijenhuis, Ronak Delewi, Renicus Suffridus Hermanides, Wouter Holvoet, Christophe Dubois, Peter Frambach, Bernard De Bruyne, Gert K. van Houwelingen, Jan A.S. Van der Heyden et al. · 2020 · New England Journal of Medicine
23. ACC/AHA/SCAI Practice Guidelines, February 21, 2006
    2006 · Circulation
24. Reducing the Global Burden of Cardiovascular Disease, Part 2
    Darryl P. Leong, Philip G. Joseph, Martin McKee, Sonia Savitri Anand, Koon Kang Teo, Jon-David Schwalm, Salim Yusuf · 2017 · Circulation Research
25. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial
    Robert F. van Es, Jan J C Jonker, Freek W.A. Verheugt, Jaap Willem Deckers, Diederick E. Grobbee · 2002 · The Lancet
26. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial
    Ka Sing Wong, Christopher Chen, Jianhui Fu, Hui Meng Chang, Nijasri Charnnarong Suwanwela, Yining N Huang, Zhao Han, Kay Sin Tan, Disya Ratanakorn, Pavithra Chollate et al. · 2010 · The Lancet Neurology
27. Vascular Complications of Diabetes
    Joshua A. Beckman, Mark A. Creager · 2016 · Circulation Research
28. Aspirin and Clopidogrel
    Marco Cattaneo · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
29. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Jack Hirsh, Gordon Henry Guyatt, Gregory W. Albers, Holger Jens Schünemann · 2004 · CHEST Journal
30. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
    Bhatt, Deepak L, Marso, Steven P, Hirsch, Alan T, Ringleb, Peter A, Hacke, Werner, Topol, Eric J · 2002 · The American Journal of Cardiology
31. Scientific and therapeutic advances in antiplatelet therapy
    Deepak L. Bhatt, Eric J. Topol · 2002 · Nature Reviews Drug Discovery
32. Antiplatelet therapies for the treatment of cardiovascular disease
    Alan D. Michelson · 2010 · Nature Reviews Drug Discovery
33. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
    Marco Valgimigli, Héctor Bueno, Robert A. Byrne, Jean‐Philippe Collet, Francesco Costa, Anders Jeppsson, Peter Jüni, Adnan Kastrati, Philippe H. Kolh, Laura Mauri et al. · 2017 · European Journal of Cardio-Thoracic Surgery
34. Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology
    Carlo Patrono · 2003 · European Heart Journal
35. P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use
    Lars C. Wallentin · 2009 · European Heart Journal
36. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study
    Hallas, Jesper, Dall, Michael, Andries, Alin, Andersen, Birthe Søgaard, Aalykke, Claus, Hansen, Jane Møller, Andersen, Morten, Lassen, Annmarie Touborg · 2006 · BMJ
37. Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials
    Kenneth R. McQuaid, Loren Laine · 2006 · The American Journal of Medicine
38. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
    Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh G Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten et al. · 2009 · Circulation
39. Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
    Stefan Karl James, Axel Åkerblom, Christopher Paul Cannon, Håkan Emanuelsson, Steen Husted, Hugo Albert Katus, Allan M. Skene, Philippe Gabríel Steg, Robert F. Storey, Robert A. Harrington et al. · 2009 · American Heart Journal
40. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases
    Boris Aleil, Catherine Ravanat, Jean‐Pierre Cazenave, G Rochoux, Anja Heitz, Christian Gachet · 2004 · Journal of Thrombosis and Haemostasis
41. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations
    Laura Kristin Newby, Robert L. Jesse, Joseph D. Babb, Robert H. Christenson, Thomas M. De Fer, George A. Diamond, Francis M. Fesmire, Stephen A. Geraci, Bernard John Gersh, Greg C. Larsen et al. · 2012 · Journal of the American College of Cardiology
42. Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
    Nagy A. Farid, Atsushi Kurihara, Steven A. Wrighton · 2009 · The Journal of Clinical Pharmacology
43. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations.
    Laxmaiah Manchikanti, Salahadin Abdi, Sairam L Atluri, Ramsin M Benyamin, Mark V. Boswell, Ricardo M Buenaventura, David A. Bryce, Patricia A Burks, David L. Caraway, Aaron K. Calodney et al. · 2013 · PubMed
44. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
    Miguel Sousa‐Uva, Stuart J. Head, Milan Milojevic, Jean‐Philippe Collet, Giovanni Landoni, Manuel Castellà, Joel Dunning, Tómas Guðbjartsson, Nick Linker, Elena Sandoval et al. · 2017 · European Journal of Cardio-Thoracic Surgery
45. Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons
    Amir Qaseem, Stephan D. Fihn, Sankey Williams, Paul Dallas, Douglas K Owens, Paul Shekelle · 2012 · Annals of Internal Medicine
46. Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome
    P. Michael Ho · 2008 · JAMA
47. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
    Linxin Li, Olivia C. Geraghty, Ziyah Mehta, Peter Malcolm Rothwell · 2017 · The Lancet
48. Diabetes and Vascular Disease
    Thomas Felix Lüscher, Mark A. Creager, Joshua A. Beckman, Francesco Cosentino · 2003 · Circulation
49. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
    Deepak L. Bhatt, James M. Scheiman, Neena S. Abraham, Elliott Marshall Antman, Francis K.L. Chan, Curt Daniel Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M.M. Quigley, Robert A. Harrington et al. · 2008 · Journal of the American College of Cardiology
50. Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
    Jessica L. Mega, Willibald Hochholzer, Andrew L. Frelinger, Michael Kluk, Dominick Joseph Angiolillo, Dean J. Kereiakes, Steven Isserman, William J. Rogers, Christian Thomas Ruff, Charles Contant et al. · 2011 · JAMA
51. Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
    Jean‐Sébastien Hulot, Jean‐Philippe Collet, Johanne Silvain, Ana Peña, Anne Bellemain-Appaix, Olivier Barthélémy, Guillaume Cayla, Farzin Beygui, Gilles Montalescot · 2010 · Journal of the American College of Cardiology
52. Acute Coronary Syndromes: Diagnosis and Management, Part I
    Amit Kumar, Christopher Paul Cannon · 2009 · Mayo Clinic Proceedings
53. Antiplatelet Drugs
    John W. Eikelboom, Jack Hirsh, Frederick Alan Spencer, Trevor P Baglin, Jeffrey Ian Weitz · 2012 · CHEST Journal
54. Stroke
    Charles P Warlow, Cathie L. M. Sudlow, Martin S. Dennis, Joanna Marguerite Wardlaw, Peter AG Sandercock · 2003 · The Lancet
55. Cardiovascular Manifestations of Hypereosinophilic Syndromes
    Ogbogu, Princess U., Rosing, Douglas R., Horne, McDonald K. · 2007 · Immunology and Allergy Clinics of North America
56. High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
    Thomas Cuisset, Corinne Frère, Jacques Quilici, Franck Barbou, Pierre‐Emmanuel Morange, Thomas Hovasse, J-L Bonnet, Marie‐Christine Alessi · 2005 · Journal of Thrombosis and Haemostasis
57. Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
    Jean‐Philippe Collet, Gilles Montalescot, Benoı̂t Blanchet, Marie‐Laure Tanguy, Jean‐Louis Golmard, Rémi Choussat, Farzin Beygui, Laurent Payot, Nicolas Vignolles, J.P. Metzger et al. · 2004 · Circulation
58. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial
    Lars C. Wallentin, Robert G. Wilcox, W Douglas Weaver, Håkan Emanuelsson, Andrew Goodvin, Per Olof Nyström, Anders L. Bylock · 2003 · The Lancet
59. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
    Davide Capodanno, Fernándo Alfonso, Glenn N. Levine, Marco Valgimigli, Dominick Joseph Angiolillo · 2018 · Journal of the American College of Cardiology
60. Platelet Physiology
    Andrew L. Frelinger, Alan D. Michelson, Thomas Gremmel · 2016 · Seminars in Thrombosis and Hemostasis
61. Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)
    Steen Husted, Lars C. Wallentin, Felicita Andreotti, Harald Arnesen, F Bachmann, Colin Baigent, Kurt Huber, Jørgen Jespersen, Steen Dalby Kristensen, Gregory Y.H. Lip et al. · 2013 · Thrombosis and Haemostasis
62. Purinergic receptor P2RY12-dependent microglial closure of the injured blood–brain barrier
    Lou, Nanhong, Takano, Takahiro, Pei, Yong, Xavier, Anna L., Goldman, Steven A., Nedergaard, Maiken · 2016 · Proceedings of the National Academy of Sciences
63. Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
    Steen Husted, Lars C. Wallentin, Felicita Andreotti, Harald Arnesen, Fedor Bachmann, Colin Baigent, Kurt Huber, Jørgen Jespersen, Steen Dalby Kristensen, Gregory Y.H. Lip et al. · 2013 · Thrombosis and Haemostasis
64. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial
    J. J. F. Belch, John Dormandy · 2010 · Journal of Vascular Surgery
65. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
    Deepak L. Bhatt, Michel E. Bertrand, Peter B. Berger, Philippe L. L’Allier, Issam Moussa, Jeffrey W. Moses, George Dangas, Megumi Taniuchi, John M. Lasala, David R. Holmes et al. · 2002 · Journal of the American College of Cardiology
66. Patients with peripheral arterial disease in the CHARISMA trial
    P. Cacoub, Deepak L. Bhatt, Philippe Gabríel Steg, Eric J. Topol, Mark A. Creager, for the CHARISMA Investigators · 2008 · European Heart Journal
67. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries
    Patrick André, Suzanne M. Delaney, Thomas LaRocca, Diana Vincent, Francis R. DeGuzman, Marzena Jurek, Beverley Koller, David R. Phillips, Pamela B. Conley · 2003 · Journal of Clinical Investigation
68. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
    2011 Writing Group Members, R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Théodore G. Ganiats, Hani M. Jneid et al. · 2011 · Circulation
69. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy
    Robert A. Henderson, Stuart Pocock, Tim C. Clayton, Rochelle Knight, Keith A.A. Fox, Desmond G. Julian, Douglas A. Chamberlain · 2003 · Journal of the American College of Cardiology
70. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
    Marieke E. Gimbel, Khalid Qaderdan, Laura M. Willemsen, Rik S. Hermanides, Thomas O. Bergmeijer, Evelyn A. de Vrey, Ton A.C.M. Heestermans, Melvyn Tjon Joe Gin, Reinier A. Waalewijn, Sjoerd H. Hofma et al. · 2020 · The Lancet
71. Avoiding Central Nervous System Bleeding During Antithrombotic Therapy
    Robert G. Hart, Silvina B. Tonarelli, Lesly A. Pearce · 2005 · Stroke
72. Novel antiplatelet agents in acute coronary syndrome
    Francesco Franchi, Dominick Joseph Angiolillo · 2014 · Nature Reviews Cardiology
73. Clinical Aspects of Platelet Inhibitors and Thrombus Formation
    Telly A. Meadows, Deepak L. Bhatt · 2007 · Circulation Research
74. Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management
    Olin, Jeffrey W., Sealove, Brett A. · 2010 · Mayo Clinic Proceedings
75. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
    Lori J. Mosca, Lawrence J. Appel, Emelia J. Benjamin, Kathy A. Berra, Nisha Chandra‐Strobos, Rosalind P. Fabunmi, Deborah G. Grady, Constance K. Haan, Sharonne N. Hayes, Debra R. Judelson et al. · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
76. Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials
    Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger, Alex I. Malinin, Jeffrey S. Baggish, Deepak L. Bhatt, Eric J. Topol · 2005 · The American Journal of Cardiology
77. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2011 · Circulation
78. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis
    Mary Frances McMullin, David Bareford, Peter J. Campbell, Anthony Richard Green, Claire N. Harrison, Beverley Jane Hunt, David Graham Oscier, Michael Iain Polkey, John T. Reilly, Éric Rosenthal et al. · 2005 · British Journal of Haematology
79. Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting
    Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Lyassine Nait-Saïdi, Joseph Carvajal, Agnès Lehmann, Marc Lambert, Jean-Louis Bonnet, Marie‐Christine Alessi · 2006 · Journal of the American College of Cardiology
80. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
    R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Théodore G. Ganiats, Hani M. Jneid, Abraham Michael Lincoff et al. · 2011 · Journal of the American College of Cardiology
81. Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist
    Steen Husted, J.J.J. van Giezen · 2009 · Cardiovascular Therapeutics
82. Sensitivity and Specificity of the Ankle–Brachial Index to Predict Future Cardiovascular Outcomes
    Anand V. Doobay, Sonia Savitri Anand · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
83. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
    Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh G Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten et al. · 2009 · Journal of the American College of Cardiology
84. World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
    Glenn N. Levine, Young‐Hoon Jeong, Shinya Goto, Jeffrey L. Anderson, Yong Huo, Jessica L. Mega, Kathryn A. Taubert, Sidney C. Smith · 2014 · Nature Reviews Cardiology
85. Acute Coronary Syndromes: Diagnosis and Management, Part II
    Amit Kumar, Christopher Paul Cannon · 2009 · Mayo Clinic Proceedings
86. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    M. Lamberts, G. Gislason, J. Olesen, S. Kristensen, A. Schjerning Olsen, A. Mikkelsen, C. B. Christensen, G. Lip, L. Køber, C. Torp-Pedersen et al. · 2013 · Journal of the American College of Cardiology
87. Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
    Michael B. Rothberg, Carmel Celestin, Louis D. Fiore, Elizabeth V. Lawler, James R. Cook · 2005 · Annals of Internal Medicine
88. Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading
    Julinda Mehilli, Adnan Kastrati, Stefanie Schulz, Stefan Früngel, Stephan G. Nekolla, Werner E.L. Moshage, Franz Dotzer, Kurt Huber, Jürgen Pache, Josef Dirschinger et al. · 2009 · Circulation
89. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial
    Marco Valgimigli, Francesco Costa, Yuliya V. Lokhnygina, Robert M. Clare, Lars C. Wallentin, David J. Moliterno, Paul W. Armstrong, Harvey Douglas White, Claes Held, Philip E. Aylward et al. · 2016 · European Heart Journal
90. Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
    John L. Petersen, Kenneth W. Mahaffey, Vic Hasselblad, Elliott Marshall Antman, Marc C. Cohen, Shaun G. Goodman, Anatoly Langer, Michael A. Blazing, Anne Le Moigne-Amrani, James A. de Lemos et al. · 2004 · JAMA
91. Chronic Coronary Artery Disease: Diagnosis and Management
    Andrew Cassar, David R. Holmes, Charanjit S. Rihal, Bernard John Gersh · 2009 · Mayo Clinic Proceedings
92. Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
    Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, Ko Yamamoto, Yuki Obayashi, Manabu Ogita, Satoru Suwa, Tsuyoshi Isawa, Takenori Domei, Kyohei Yamaji et al. · 2022 · JAMA Cardiology
93. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement
    Dirk Sibbing, Stefanie Schulz, S. Braun, Tanja Morath, Julia Stegherr, Julinda Mehilli, Albert Schömig, Nicolas von Beckerath, Adnan Kastrati · 2009 · Journal of Thrombosis and Haemostasis
94. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)
    Stephen D. Wiviott, Elliott Marshall Antman, Charles Michael Gibson, Gilles Montalescot, Jeffrey S. Riesmeyer, Govinda J. Weerakkody, Kenneth J. Winters, Jeffrey W. Warmke, Carolyn H. McCabe, Eugene Braunwald M. D · 2006 · American Heart Journal
95. Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently
    N A Farid, Christopher D. Payne, D. S. Small, Kenneth J. Winters, C. Steven Ernest, John T. Brandt, Christelle Darstein, Joseph A. Jakubowski, Daniel E. Salazar · 2007 · Clinical Pharmacology & Therapeutics
96. Coronary Artery Disease in Patients ≥80 Years of Age
    Mahesh V. Madhavan, Bernard John Gersh, Karen P. Alexander, Christopher Bull Granger, Gregg W. Stone · 2018 · Journal of the American College of Cardiology
97. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
    P.-G. Chassot, Alain Delabays, Donat Rudolf Spahn · 2007 · British Journal of Anaesthesia
98. Evolution in Cardiovascular Care for Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
    Karen P. Alexander, Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, JoAnne Micale Foody, William E. Boden, Sidney C. Smith, W. Brian Gibler, E. Magnus Ohman et al. · 2005 · Journal of the American College of Cardiology
99. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
    Gregory W. Albers, Pierre Amarenco, J. Donald Easton, Ralph L. Sacco, Philip A. Teal · 2008 · CHEST Journal
100. 2023 ESC Guidelines for the management of acute coronary syndromes
     Robert A. Byrne, Xavier Rosselló, John Joseph Coughlan, Emanuele Barbato, Colin Berry, Alaide Chieffo, Marc J. Claeys, Gheorghe‐Andrei Dan, Marc Richard Dweck, Mary Galbraith et al. · 2023 · European Heart Journal Acute Cardiovascular Care